173 related articles for article (PubMed ID: 25619894)
1. Synthesis and anticancer cell potential of steroidal 16,17-seco-16,17a-dinitriles: identification of a selective inhibitor of hormone-independent breast cancer cells.
Nikolić AR; Petri ET; Klisurić OR; Ćelić AS; Jakimov DS; Djurendić EA; Penov Gaši KM; Sakač MN
Bioorg Med Chem; 2015 Feb; 23(4):703-11. PubMed ID: 25619894
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity of novel steroidal 6-substituted 4-en-3-one D-seco dinitriles.
Nikolić AR; Kuzminac IZ; Jovanović-Šanta SS; Jakimov DS; Aleksić LD; Sakač MN
Steroids; 2018 Jul; 135():101-107. PubMed ID: 29604312
[TBL] [Abstract][Full Text] [Related]
3. N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
Brossard D; Zhang Y; Haider SM; Sgobba M; Khalid M; Legay R; Duterque-Coquillaud M; Galera P; Rault S; Dallemagne P; Moslemi S; El Kihel L
Chem Biol Drug Des; 2013 Nov; 82(5):620-9. PubMed ID: 23906044
[TBL] [Abstract][Full Text] [Related]
4. 17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.
Ajduković JJ; Djurendić EA; Petri ET; Klisurić OR; Celić AS; Sakač MN; Jakimov DS; Gaši KM
Bioorg Med Chem; 2013 Dec; 21(23):7257-66. PubMed ID: 24148837
[TBL] [Abstract][Full Text] [Related]
5. Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells - QSAR approach and molecular docking analysis.
Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Vukić VR; Savić MP; Djurendić EA
Eur J Pharm Sci; 2016 Oct; 93():107-13. PubMed ID: 27503457
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer potential of novel 5,6-oxygenated and/or halogenated steroidal d-homo lactones.
Kuzminac IZ; Jakimov DS; Bekić SS; Ćelić AS; Marinović MA; Savić MP; Raičević VN; Kojić VV; Sakač MN
Bioorg Med Chem; 2021 Jan; 30():115935. PubMed ID: 33340938
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel steroidal imidazoles as dual inhibitors of AR/CYP17 for the treatment of prostate cancer.
Hou Q; He C; Lao K; Luo G; You Q; Xiang H
Steroids; 2019 Oct; 150():108384. PubMed ID: 30885648
[TBL] [Abstract][Full Text] [Related]
8. Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme.
Daniilides K; Lougiakis N; Evangelidis T; Kostakis IK; Pouli N; Marakos P; Mikros E; Skaltsounis AL; Bach S; Baratte B; Ruchaud S; Karamani V; Papafotika A; Christoforidis S; Argyros O; Kouvari E; Tamvakopoulos C
Anticancer Agents Med Chem; 2017; 17(7):990-1002. PubMed ID: 27928955
[TBL] [Abstract][Full Text] [Related]
9. Discovery of highly potent proapoptotic antiestrogens in a series of androst-5,16-dienes D-modified with imidazole-annulated pendants.
Birukova V; Scherbakov A; Ilina A; Salnikova D; Andreeva O; Dzichenka Y; Zavarzin I; Volkova Y
J Steroid Biochem Mol Biol; 2023 Jul; 231():106309. PubMed ID: 37037385
[TBL] [Abstract][Full Text] [Related]
10. Identification of d-seco modified steroid derivatives with affinity for estrogen receptor α and β isoforms using a non-transcriptional fluorescent cell assay in yeast.
Bekić SS; Marinović MA; Petri ET; Sakač MN; Nikolić AR; Kojić VV; Ćelić AS
Steroids; 2018 Feb; 130():22-30. PubMed ID: 29224741
[TBL] [Abstract][Full Text] [Related]
11. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
12. Steroidal N-Sulfonylimidates: Synthesis and biological evaluation in breast cancer cells.
Volkova YA; Kozlov AS; Kolokolova MK; Uvarov DY; Gorbatov SA; Andreeva OE; Scherbakov AM; Zavarzin IV
Eur J Med Chem; 2019 Oct; 179():694-706. PubMed ID: 31284080
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a multi-target compound for estrogen receptor-positive (ER
Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel bis(1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile) and bis(1,4-dihydropyrazolo[4',3':5,6]pyrano[2,3-b]pyridine-6-carbonitrile) derivatives.
Salama SK; Mohamed MF; Darweesh AF; Elwahy AH; Abdelhamid IA
Bioorg Chem; 2017 Apr; 71():19-29. PubMed ID: 28143658
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent.
Mokale SN; Sakle NS; Bhavale SA; Lokwani DK; Shelke VR
Anticancer Agents Med Chem; 2018; 18(7):1009-1015. PubMed ID: 29189180
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity evaluation of steroidal imidazo[1,2-a]pyridines.
Rassokhina IV; Volkova YA; Kozlov AS; Scherbakov AM; Andreeva OE; Shirinian VZ; Zavarzin IV
Steroids; 2016 Sep; 113():29-37. PubMed ID: 27263438
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of the antiproliferative activity of benzylidenes of 16-dehydroprogesterone series.
Scherbakov AM; Zavarzin IV; Vorontsova SK; Hajra A; Andreeva OE; Yadykov AV; Levina IS; Volkova YA; Shirinian VZ
Steroids; 2018 Oct; 138():91-101. PubMed ID: 29997047
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and X-ray analysis of bicalutamide sulfoxide analogues for the potential treatment of prostate cancer.
Kandil SB; Kariuki BM; McGuigan C; Westwell AD
Bioorg Med Chem Lett; 2021 Mar; 36():127817. PubMed ID: 33513386
[TBL] [Abstract][Full Text] [Related]
20. 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
Kandil S; Westwell AD; McGuigan C
Bioorg Med Chem Lett; 2016 Apr; 26(8):2000-4. PubMed ID: 26965862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
